Senior Pharmacoepidemiologist
Office of Surveillance and Epidemiology, CDER, FDA
Dr Marie Bradley is a pharmacoepidemiologist and a pharmacist with over 13 years of experience working in regulatory, government and academic sectors in Europe and the US. She currently serves as a Senior Pharmacoepidemiologist in the Office of Surveillance and Epidemiology, the Center for Drug Evaluation and Research, at the US Food and Drug Administration (FDA). Here, she leads pharmacoepidemiologic studies and regulatory reviews concerning drug safety in the rheumatology, pulmonary, allergy cardiology and nephrology spaces, and advises on the use of real-world evidence in regulatory decision making. Dr Bradley has MPharm and PhD degrees from Queen’s University Belfast, a MSPH degree from The London School of Hygiene and Tropical Medicine and completed a Cancer Prevention Fellowship at the National Cancer Institute, in the US.